Literature DB >> 12788071

Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease.

Hiroshi Manya1, Keiwa Sakai, Kazuhiro Kobayashi, Kiyomi Taniguchi, Masao Kawakita, Tatsushi Toda, Tamao Endo.   

Abstract

Muscle-eye-brain disease (MEB), an autosomal recessive disorder, is characterized by congenital muscular dystrophy, brain malformation, and ocular abnormalities. Previously, we found that MEB is caused by mutations in the gene encoding the protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1), which is responsible for the formation of the GlcNAcbeta1-2Man linkage of O-mannosyl glycan. Although 13 mutations have been identified in patients with MEB, only the protein with the most frequently observed splicing site mutation has been studied. This protein was found to have no activity. Here, we expressed the remaining mutant POMGnT1s and found that none of them had any activity. These results clearly demonstrate that MEB is inherited as a loss-of-function of POMGnT1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12788071     DOI: 10.1016/s0006-291x(03)00924-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration.

Authors:  Masaji Tachikawa; Motoi Kanagawa; Chih-Chieh Yu; Kazuhiro Kobayashi; Tatsushi Toda
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

2.  O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.

Authors:  Mauro Imperiali; Claudio Thoma; Ernesto Pavoni; Andrea Brancaccio; Nico Callewaert; Annette Oxenius
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Mutations in POMGNT1 cause non-syndromic retinitis pigmentosa.

Authors:  Mingchu Xu; Takeyuki Yamada; Zixi Sun; Aiden Eblimit; Irma Lopez; Feng Wang; Hiroshi Manya; Shan Xu; Li Zhao; Yumei Li; Adva Kimchi; Dror Sharon; Ruifang Sui; Tamao Endo; Robert K Koenekoop; Rui Chen
Journal:  Hum Mol Genet       Date:  2016-01-28       Impact factor: 6.150

4.  A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.

Authors:  Tomoko Yamamoto; Yoichiro Kato; Noriyuki Shibata; Tatsuo Sawada; Makiko Osawa; Makio Kobayashi
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

Review 5.  Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.

Authors:  Paul T Martin
Journal:  Nat Clin Pract Neurol       Date:  2006-04

6.  Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2.

Authors:  Ida Signe Bohse Larsen; Yoshiki Narimatsu; Hiren Jitendra Joshi; Zhang Yang; Oliver J Harrison; Julia Brasch; Lawrence Shapiro; Barry Honig; Sergey Y Vakhrushev; Henrik Clausen; Adnan Halim
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

Review 7.  The dystroglycanopathies: the new disorders of O-linked glycosylation.

Authors:  Paul T Martin
Journal:  Semin Pediatr Neurol       Date:  2005-09       Impact factor: 1.636

8.  Muscular dystrophy associated with alpha-dystroglycan deficiency in Sphynx and Devon Rex cats.

Authors:  Paul T Martin; G Diane Shelton; Peter J Dickinson; Beverly K Sturges; Rui Xu; Richard A LeCouteur; Ling T Guo; Robert A Grahn; Harriet P Lo; Kathryn N North; Richard Malik; Eva Engvall; Leslie A Lyons
Journal:  Neuromuscul Disord       Date:  2008-11-05       Impact factor: 4.296

9.  Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.

Authors:  Naoyuki Kuwabara; Hiroshi Manya; Takeyuki Yamada; Hiroaki Tateno; Motoi Kanagawa; Kazuhiro Kobayashi; Keiko Akasaka-Manya; Yuriko Hirose; Mamoru Mizuno; Mitsunori Ikeguchi; Tatsushi Toda; Jun Hirabayashi; Toshiya Senda; Tamao Endo; Ryuichi Kato
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-04       Impact factor: 11.205

10.  Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients.

Authors:  Hui Jiao; Hiroshi Manya; Shuo Wang; Yanzhi Zhang; Xiaoqing Li; Jiangxi Xiao; Yanling Yang; Kazuhiro Kobayashi; Tatsushi Toda; Tamao Endo; Xiru Wu; Hui Xiong
Journal:  Mol Genet Genomics       Date:  2013-05-21       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.